Navigation Links
Whistleblower Comments on Hawthorn Pharmaceuticals' $2.8 Million Settlement of His Medicaid Fraud Qui Tam Case
Date:3/28/2012

PLANO, Texas, March 28, 2012 /PRNewswire/ -- Hawthorn Pharmaceuticals Inc. and its parent company, Cypress Pharmaceutical Inc., have paid the federal government and certain states a total of $2.8 million to settle a whistleblower lawsuit filed by Phillips & Cohen LLP that alleged Hawthorn falsely marketed unapproved prescription drugs as being eligible for reimbursement by Medicaid and other government health care programs.

An even bigger result of the "qui tam" (whistleblower) lawsuit -- which was filed "under seal" in 2007 in Plano, Texas, and made public today -- was that government health care programs stopped purchasing unapproved Hawthorn prescription drugs during the government investigation of the whistleblower's claims. Those drugs included cough and cold drugs, hydrocodone products and timed-release products using unapproved "tannate" formulations of drug ingredients.

The whistleblower, Robert Heiden, is a former district sales manager for Hawthorn in Florida. He is represented by Phillips & Cohen LLP.

ROBERT HEIDEN, THE WHISTLEBLOWER: "The impact of this case goes beyond the money recovered. Unapproved and unsafe drugs sold by Hawthorn and other companies have been pulled off Medicaid and Medicare reimbursement lists, protecting consumers and saving taxpayers hundreds of millions of dollars."

"My case and the government's response mean that children, from infants to adolescents, now are protected from the dangers of certain drugs whose safety and effectiveness haven't been determined. With the removal of the drugs from government reimbursement lists, doctors are shielded from prescribing drugs they had been misled to believe were FDA-approved, and parents will no longer be giving their children drugs they didn't realize hadn't been approved by the FDA."

ATTORNEY COLETTE G. MATZZIE, PHILLIPS & COHEN LLP, WASHINGTON, DC: "A whistleblower
'/>"/>

SOURCE Phillips & Cohen LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Prescription Drug Manufacturers Underpaid Medicaid Rebates, Federal and State Whistleblower Complaint Alleges
2. Whistleblower Lawyers Comment on New England Journal of Medicine Study
3. Whistleblower Doctor Comments on His Case that Helped Expose Illegal Marketing of Topamax
4. Whistleblower Kickback Case Against Alpharma Results In $42.5 Million Recovery for U.S. and States
5. Pfizer Whistleblower Named Years Most Influential Person In Business Ethics
6. Whistleblowers Attorney Says Pfizers Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies
7. NCPA Comments on FTC Action Against CVS Caremark, Vows to Continue PBM Transparency Efforts
8. Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance
9. K-V Pharmaceutical Company Comments on Recent Settlement With the Department of Justice
10. Rock Creek Pharmaceuticals Announces Completion of Medical Conferences on Anatabloc™ Research, Comments on Research Presentation at American Thyroid Association Annual Meeting
11. K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 20, 2014 Pharmaceutic Labs announces the opening ... Albany, NY for admixing, compounding, drug ... and/or exceeds the FDA standards for safety and quality, ... 211. The 10,000 square foot outsourcing ... quality assurance and quality control. The company will produce ...
(Date:10/19/2014)... , Oct. 20, 2014 CTI BioPharma ... it will report its third quarter 2014 financial results ... the U.S. financial markets. Following the announcement, members of ... to discuss the results and provide a general corporate ... to the event can be obtained as follows: ...
(Date:10/17/2014)... 2014  Training market researchers to spot and ... in today,s highly competitive global marketplace. As resources ... effectively and efficiently produce high performing analysts, regardless ... Effective training programs can help these ... internal clients by developing analysts who can drive ...
Breaking Medicine Technology:CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive and ... platform to think outside the bra. She doesn’t try to ... raise awareness about women’s other lady parts. , "We have ... the color pink and everybody knows what you’re talking about,” ... it has not been won when it comes to gynecologic ...
(Date:10/20/2014)... San Diego, CA (PRWEB) October 20, 2014 ... regarding all the latest information from the FDA on ... consumers on October 10 not to purchase or use Sit ... Phenolphthalein. Sit and Slim II is promoted as weight loss ... , Sibutramine, removed from the market in 2010 for safety ...
(Date:10/20/2014)... 2014 Based on a proprietary ... imaging assays capable of determining DNA sequence, location ... these three dimensions of high-resolution data, dGH assays ... widest range of disease-causing genetic rearrangements, including chromosomal ... genomic tools, including today’s advanced sequencing technologies. , ...
(Date:10/20/2014)... It’s hard to imagine what it’s like ... children around the world, it’s a reality. And while new ... are forced to walk barefoot on rocky terrain or sewage-lined ... with their friends. , Buckner International's Shoes for ... in October to encourage support for Air1 and while ...
(Date:10/19/2014)... Hastings and Hastings, a Phoenix personal injury law ... greater Phoenix area and across Arizona reports record demand ... automobile accidents. Statistics have indicated a steady increase in ... such, Hastings and Hastings has seen a steady increase ... have been injured through no fault of their own ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3
... In the first ever threadbare genetic study of Alzheimer’s, reports ... 79% of the cases, is genetically linked. // ... to it. The disease is marked by apparent confusion, memory ... a place in the Archives of General Psychiatry,However genes cannot ...
... has been an increase in heart failure cases among the elderly, ... men surviving for longer periods. There has been a 14% increase ... period when compared to the 1970 to 1974 period, in the ... ,The chances of heart failure occurring among people ...
... produced by Roche Pharmaceuticals, has been approved by the ... prevention drug in children’s between the ages of 1 ... leading healthcare company situated in Switzerland and are manufacturers ... to be an effective influenza virus drug, which inhibits ...
... leaders, particularly in South Asia to prohibit smoking among the ... the British Medical Journal (BMJ). The help of the Muslim ... ,The researchers analyzed data on the prevalence of smoking ... Smoking rates in each of these countries is significantly higher ...
... who suffer from eating disorders do not reveal it to anyone ... six months. As many as 1,000 youngsters were studied, and the ... of recognizing such disorders in their children, while only 21% of ... ,The research was conducted by the Eating Disorders Association ...
... charges cost so dear, that cancer patients, ill afford ... Charity Breast Cancer Care, 42% of breast cancer patients, ... financial incapacity to afford the prescription charges. Out of ... 15% said they were forced to discontinue the treatment ...
Cached Medicine News:Health News:Eating Disorders Among Children Are Widespread 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: